or Try an Advanced Search...

    Technical Analysis for RPHM - Reneo Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 1.55 2.65% 0.04
    RPHM closed up 2.65 percent on Monday, July 1, 2024, on 40 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical RPHM trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Inside Day Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    Volume Surge Other 2.65%
    Below Lower BB Weakness 2.65%
    Lower Bollinger Band Touch Weakness 2.65%
    Oversold Stochastic Weakness 2.65%
    Oversold Stochastic Weakness -3.73%
    Oversold Stochastic Weakness -1.27%
    Narrow Range Bar Range Contraction -3.73%
    Older End-of-Day Signals for RPHM ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    10 DMA Resistance about 9 hours ago
    Up 1 ATR about 9 hours ago
    Rose Above 10 DMA about 10 hours ago
    Up 5% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    RPHM Chart by TradingView
    Basic chart:

    Profile

    Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. The company was incorporated in 2014 and is headquartered in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Clinical Research Clinical Trial Stage Pharmaceutical Transcription Factors Carboxylic Acids Intracellular Receptors

    Is RPHM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 17 Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
    May 13 Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise
    May 13 Reneo Pharmaceuticals gains on deal to merge with OnKure
    May 13 Reneo Pharmaceuticals and OnKure Announce Proposed Merger
    May 7 Reneo Pharmaceuticals GAAP EPS of -$0.25
    May 7 Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
    Mar 28 Reneo Pharmaceuticals GAAP EPS of -$2.52
    Mar 28 Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
    Mar 25 Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
    See more RPHM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.18
    52 Week Low 0.9801
    Average Volume 315,957
    200-Day Moving Average 3.45
    50-Day Moving Average 1.69
    20-Day Moving Average 1.64
    10-Day Moving Average 1.59
    Average True Range 0.09
    RSI (14) 40.83
    ADX 14.02
    +DI 19.21
    -DI 18.17
    Chandelier Exit (Long, 3 ATRs) 1.67
    Chandelier Exit (Short, 3 ATRs) 1.77
    Upper Bollinger Bands 1.76
    Lower Bollinger Band 1.52
    Percent B (%b) 0.12
    BandWidth 14.41
    MACD Line -0.04
    MACD Signal Line -0.03
    MACD Histogram -0.0106
    Fundamentals Value
    Market Cap 51.63 Million
    Num Shares 33.3 Million
    EPS -2.36
    Price-to-Earnings (P/E) Ratio -0.66
    Price-to-Sales 0.00
    Price-to-Book 0.48
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.67
    Resistance 3 (R3) 1.68 1.64 1.65
    Resistance 2 (R2) 1.64 1.61 1.64 1.64
    Resistance 1 (R1) 1.60 1.59 1.62 1.59 1.64
    Pivot Point 1.56 1.56 1.58 1.56 1.56
    Support 1 (S1) 1.52 1.53 1.54 1.51 1.46
    Support 2 (S2) 1.48 1.51 1.48 1.46
    Support 3 (S3) 1.44 1.48 1.45
    Support 4 (S4) 1.43